MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$28,136,757
Net Income
-$452,864
Net Profit Margin
-1.61%
EPS
-$0.05
Unit: Dollar
Revenue Breakdown
Soft Tissue Repair Products
Bone Fusion Products
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Net revenue
28,136,757
27,519,233
26,333,819
25,830,834
Cost of goods sold
1,981,347
1,874,506
1,874,214
1,937,282
Gross profit
26,155,410
25,644,727
24,459,605
23,893,552
Selling, general and administrative
22,601,690
15,845,320
19,877,875
21,553,194
Research and development
1,154,232
1,671,279
1,029,591
1,257,475
Depreciation and amortization
619,111
-187,667
610,899
1,114,231
Change in fair value of earnout liabilities
-
-
-
0
Asset impairment charges
-
1,841,120
-
-
Total operating expenses
24,375,033
19,170,052
21,518,365
23,924,900
Operating income
1,780,377
6,474,675
2,941,240
-31,348
Interest expense
1,810,311
1,833,035
1,818,105
1,791,568
Share of losses from equity method investments
-433,648
-324,734
-288,642
-195,482
Interest income
53,814
-1,836*
-
0
Loss (gain) on disposal of property and equipment
-1,376
3,094*
-
0
Total other income (expense)
-2,191,521
-2,156,511
-2,106,747
-1,987,050
Net income (loss) from continuing operations
-411,144
-2,896,603*
834,493
-
Net income (gain) from discontinued operations (note 3)
-41,720
1,286,445*
-31,246,601
-
Net income (loss)
-452,864
-1,610,158
-30,412,108
-2,018,398
Net loss attributable to noncontrolling interest from continuing operations
-
-244
-955
-
Less total net loss attributable to noncontrolling interest
-
-244
-955
-4,036
Net income (loss) attributable to sanara medtech shareholders
-452,864
-1,609,914
-30,411,153
-2,014,362
Basic EPS
-0.05
-0.186
-3.52
-0.23
Diluted EPS
-0.05
-0.192
-3.4
-0.23
Basic Average Shares
8,662,671
8,662,354
8,646,668
8,612,986
Diluted Average Shares
8,662,671
8,368,288
8,940,734
8,612,986
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Soft Tissue Repair
Products
$25,242,592
(11.39%↑ Y/Y)
Bone Fusion Products
$2,894,165
(-7.91%↓ Y/Y)
Net income (loss)
attributable to sanara...
-$452,864
(77.52%↑ Y/Y)
Net revenue
$28,136,757
(8.93%↑ Y/Y)
Net income (loss)
-$452,864
(77.56%↑ Y/Y)
Gross profit
$26,155,410
(9.47%↑ Y/Y)
Cost of goods sold
$1,981,347
(2.27%↑ Y/Y)
Net income (loss)
from continuing...
-$411,144
Net income (gain)
from discontinued...
-$41,720
Operating income
$1,780,377
(5779.40%↑ Y/Y)
Total operating
expenses
$24,375,033
(1.88%↑ Y/Y)
Total other income
(expense)
-$2,191,521
(-10.29%↓ Y/Y)
Interest income
$53,814
Selling, general and
administrative
$22,601,690
(4.86%↑ Y/Y)
Research and development
$1,154,232
(-8.21%↓ Y/Y)
Depreciation and
amortization
$619,111
(-44.44%↓ Y/Y)
Interest expense
$1,810,311
(1.05%↑ Y/Y)
Share of losses from
equity method...
-$433,648
(-121.84%↓ Y/Y)
Loss (gain) on
disposal of property and...
-$1,376
Buy us a coffee
Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc. (SMTI)